Study of Patient Satisfaction With the Cancer Clinical Trial Experience

Summa Health System100 enrolled

Overview

The primary objective of this study is to evaluate the quality of the clinical trial experience of cancer patients participating in cancer research studies through Summa Health System Hospitals Cancer Research Program by evaluating patient satisfaction regarding reasons for participating, facility, consent and treatment, personal issues and overall assessment. The secondary objective of this study is to determine areas for improvement to make the patient's clinical trial experience a satisfying and positive journey.

Study Type

OBSERVATIONAL

Enrollment

100

Conditions

Cancer

Eligibility

Sex: ALLMin age: 18 YearsMax age: 80 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Participant must have participated in a clinical trial conducted by the Summa Health System Hospitals Cancer Research Program. * Participant should have been registered for clinical trial participation three months prior to receiving the satisfaction survey. Exclusion Criteria: * Participant has withdrawn consent for clinical trial participation and/or follow up. * Participant has a major medical illness that would prevent completion of the survey.

Outcomes

Primary Outcomes

Evaluation of surveys to determine if there are opportunities for performance and/or quality improvement projects.patient satisfaction regarding reasons for participating, facility, consent and treatment, personal issues and overall assessment.

Time frame: Survey will be sent to subject 3 months after study registration

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.